157 related articles for article (PubMed ID: 35315581)
41. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of IQGAP1 promotes the angiogenesis of esophageal squamous cell carcinoma through the AKT and ERK‑mediated VEGF‑VEGFR2 signaling pathway.
Li CH; Sun XJ; Niu SS; Yang CY; Hao YP; Kou JT; Li XZ; Wang XX
Oncol Rep; 2018 Sep; 40(3):1795-1802. PubMed ID: 30015941
[TBL] [Abstract][Full Text] [Related]
43. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
44. GCNT2 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma cells.
Peng F; He Q; Cheng C; Pan J
Cell Biochem Funct; 2019 Jan; 37(1):42-51. PubMed ID: 30575058
[TBL] [Abstract][Full Text] [Related]
45. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
[TBL] [Abstract][Full Text] [Related]
46. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
47. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.
Chen S; Yao L
Cancer Chemother Pharmacol; 2021 Aug; 88(2):323-334. PubMed ID: 33978839
[TBL] [Abstract][Full Text] [Related]
48. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
49. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
[TBL] [Abstract][Full Text] [Related]
50. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
[TBL] [Abstract][Full Text] [Related]
51. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses.
Pang L; Li Q; Li S; He J; Cao W; Lan J; Sun B; Zou H; Wang C; Liu R; Wei C; Wei Y; Qi Y; Hu J; Liang W; Zhang WJ; Wan M; Li F
Sci Rep; 2016 Feb; 6():22179. PubMed ID: 26916665
[TBL] [Abstract][Full Text] [Related]
52. WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade.
Yu X; Mao R; Feng W; Zhao Y; Qin J; Yang Y; Wang A; Shi Z
Exp Cell Res; 2021 Dec; 409(1):112871. PubMed ID: 34672999
[TBL] [Abstract][Full Text] [Related]
53. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma.
Shi ZZ; Wang WJ; Chen YX; Fan ZW; Xie XF; Yang LY; Chang C; Cai Y; Hao JJ; Wang MR; Bai J
Cell Death Dis; 2020 Jul; 11(7):597. PubMed ID: 32732965
[TBL] [Abstract][Full Text] [Related]
54. TGIF1 plays a carcinogenic role in esophageal squamous cell carcinoma through the Wnt/β‑catenin and Akt/mTOR signaling pathways.
Kong L; Yu Y; Guan H; Jiang L; Sun F; Li X; Huang W; Li B
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33693954
[TBL] [Abstract][Full Text] [Related]
55. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
Liu B; Li X; Li C; Xu R; Sun X
Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
[TBL] [Abstract][Full Text] [Related]
56. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
57. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
58. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
59. LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells.
Wang B; Tang D; Liu Z; Wang Q; Xue S; Zhao Z; Feng D; Sheng C; Li J; Zhou Z
PLoS One; 2021; 16(5):e0251797. PubMed ID: 34003875
[TBL] [Abstract][Full Text] [Related]
60. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
